Bristol-Myers Squibb Company (BMY): Today's Featured Health Care Winner

The health care sector closed the day up 1.9%. Transcept Pharmaceuticals Inc ( TSPT), Mela Sciences Inc ( MELA), World Heart Corporation ( WHRT), and Tranzyme Inc ( TZYM) were all winners today within the health care sector with Bristol-Myers Squibb Company ( BMY) being today's featured health care winner. Bristol-Myers Squibb Company rose 35 cents (1.1%) to $31.84 on heavy volume. Throughout the day, 23.8 million shares of Bristol-Myers Squibb Company exchanged hands as compared to its average daily volume of 13.9 million shares.

Bristol-Myers Squibb Company, a global biopharmaceutical company, discovers, develops, and delivers innovative medicines that help patients prevail over serious diseases. Bristol-Myers Squibb Company has a market cap of $53.5 billion and is part of the drugs industry. The company has a P/E ratio of 16.3, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.7. Shares are up 18.5% year to date as of the close of trading on Monday.

TheStreet Ratings rates Bristol-Myers Squibb as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front, Cormedix Inc ( CRMD), Gentiva Health Services Inc ( GTIV), Amedisys Inc ( AMED), and Uluru Inc ( ULU) were all losers within the health care sector with Theragenics Corporation ( TGX) being today's health care sector Loser Spotlight stock.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Global Stocks Ease as Investors Focus on Dollar, Oil, Italy After US-China Truce

Global Stocks Ease as Investors Focus on Dollar, Oil, Italy After US-China Truce

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes

Charlie Gasparino Says GE Is Reportedly Looking to Slash Its Dividend Again

Charlie Gasparino Says GE Is Reportedly Looking to Slash Its Dividend Again